Digital Therapeutics (DTx) And Startups — Where We Are And Where We Are Going?

2 min read

Medicine today looks drastically different than it did fifty, even ten years ago. Digital health, biotechnology, continuous sensors, the list goes on. One arena that’s been particularly revolutionized is the management of complex and chronic diseases with the aid of software enabled, disease-specific platforms. Conditions like heart disease, COPD, and diabetes have long been difficult to treat because of how interwoven their roots are with the human condition. We all know that we should choose that salad over the slice of pizza, opt for the morning run instead of the double shot of espresso, and gosh-darn-it say goodbye to those…...

This content is for DDI Basic Membership only.
Join Now
Already a member? Log in here
Amit Garg I have been in Silicon Valley for 20 years -- at Samsung NEXT Ventures, running my own startup (as of May 2019 a series D that has raised $120M and valued at $450M), at Norwest Ventures, and doing product and analytics at Google. My academic training is BS in computer science and MS in biomedical informatics, both from Stanford, and MBA from Harvard. I speak natively 3 languages, live carbon-neutral, am a 70.3 Ironman finisher, and have built a hospital in rural India serving 100,000 people.